These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38240104)

  • 1. Neurocognitive and psychosocial outcomes in survivors of childhood leukemia with Down syndrome.
    Gandy K; Hall L; Krull KR; Esbensen AJ; Rubnitz J; Jacola LM
    Cancer Med; 2024 Feb; 13(3):e6842. PubMed ID: 38240104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sleep, fatigue, and systemic inflammation on neurocognitive and behavioral outcomes in long-term survivors of childhood acute lymphoblastic leukemia.
    Cheung YT; Brinkman TM; Mulrooney DA; Mzayek Y; Liu W; Banerjee P; Panoskaltsis-Mortari A; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Cancer; 2017 Sep; 123(17):3410-3419. PubMed ID: 28452142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of neurocognitive function in long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
    Liu W; Cheung YT; Conklin HM; Jacola LM; Srivastava D; Nolan VG; Zhang H; Gurney JG; Huang IC; Robison LL; Pui CH; Hudson MM; Krull KR
    J Cancer Surviv; 2018 Jun; 12(3):398-406. PubMed ID: 29484542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks of late mortality and morbidity among survivors of childhood acute leukemia with Down syndrome: A population-based cohort study.
    Gupta S; Sutradhar R; Pequeno P; Hitzler JK; Liu N; Nathan PC
    Cancer; 2022 Mar; 128(6):1294-1301. PubMed ID: 34847248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related Quality of Life (HR-QOL) and Chronic Health Conditions in Survivors of Childhood Acute Myeloid Leukemia (AML) with Down Syndrome (DS): A Report From the Children's Oncology Group.
    Schultz KA; Chen L; Kunin-Batson A; Chen Z; Woods WG; Gamis A; Kawashima T; Oeffinger KC; Nicholson HS; Neglia JP
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):20-25. PubMed ID: 27906794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
    Goldsby RE; Stratton KL; Raber S; Ablin A; Strong LC; Oeffinger K; Sklar CA; Armstrong GT; Robison LL; Bhatia S; Leisenring WM
    Cancer; 2018 Feb; 124(3):617-625. PubMed ID: 29105081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connectivity of the Cerebello-Thalamo-Cortical Pathway in Survivors of Childhood Leukemia Treated With Chemotherapy Only.
    Phillips NS; Kesler SR; Scoggins MA; Glass JO; Cheung YT; Liu W; Banerjee P; Ogg RJ; Srivastava D; Pui CH; Robison LL; Reddick WE; Hudson MM; Krull KR
    JAMA Netw Open; 2020 Nov; 3(11):e2025839. PubMed ID: 33216140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocognitive Outcome in Very Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia After Treatment with Chemotherapy Only.
    Kanellopoulos A; Andersson S; Zeller B; Tamnes CK; Fjell AM; Walhovd KB; Westlye LT; Fosså SD; Ruud E
    Pediatr Blood Cancer; 2016 Jan; 63(1):133-8. PubMed ID: 26312396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
    Sands SA; Harel BT; Savone M; Kelly K; Vijayanathan V; Welch JG; Vrooman L; Silverman LB; Cole PD
    Support Care Cancer; 2017 Feb; 25(2):449-457. PubMed ID: 27726029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive and Behavioral Outcomes of Chinese Survivors of Childhood Lymphoblastic Leukemia.
    Peng L; Yang LS; Yam P; Lam CS; Chan AS; Li CK; Cheung YT
    Front Oncol; 2021; 11():655669. PubMed ID: 33959507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
    Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
    J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
    Roncadin C; Hitzler J; Downie A; Montour-Proulx I; Alyman C; Cairney E; Spiegler BJ
    Pediatr Blood Cancer; 2015 May; 62(5):854-8. PubMed ID: 25545182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome for Down syndrome patients with hematopoietic disorders.
    Li MJ; Lee NC; Yang YL; Yen HJ; Chang HH; Chien YH; Lu MY; Jou ST; Lin KH; Hwu WL; Lin DT
    J Formos Med Assoc; 2016 Feb; 115(2):94-9. PubMed ID: 26234152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive outcome and associated factors in long-term, adult survivors of childhood acute lymphoblastic leukemia, treated without cranial radiation therapy.
    Egset KS; Stubberud J; Ruud E; Hjort MA; Eilertsen MB; Sund AM; Hjemdal O; Weider S; Reinfjell T
    J Int Neuropsychol Soc; 2024 Jul; 30(6):523-532. PubMed ID: 38465668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.
    Stefanski KJ; Anixt JS; Goodman P; Bowers K; Leisenring W; Scott Baker K; Burns K; Howell R; Davies S; Robison LL; Armstrong GT; Krull KR; Recklitis C
    J Natl Cancer Inst; 2021 Apr; 113(4):481-495. PubMed ID: 32797189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of serial neurocognitive assessment using Cogstate during and after therapy for childhood leukemia.
    Cole PD; Kim SY; Li Y; Schembri A; Kelly KM; Sulis ML; Vrooman L; Welch JJG; Ramjan S; Silverman LB; Sands SA
    Support Care Cancer; 2023 Jan; 31(2):109. PubMed ID: 36625831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing neurocognitive late effects in childhood leukemia survivors using a combination of neuropsychological and cognitive neuroscience measures.
    Van Der Plas E; Erdman L; Nieman BJ; Weksberg R; Butcher DT; O'connor DL; Aufreiter S; Hitzler J; Guger SL; Schachar RJ; Ito S; Spiegler BJ
    Child Neuropsychol; 2018 Nov; 24(8):999-1014. PubMed ID: 29017430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Sepsis During Treatment for Childhood Leukemia and Sequelae Among Adult Survivors.
    Goggin KP; Lu L; Lee DE; Howell CR; Srivastava D; Brinkman TM; Armstrong GT; Bhakta N; Robison LL; Ehrhardt MJ; Hudson MM; Krull KR; Pui CH; Rubnitz J; Ness KK; Wolf J
    JAMA Netw Open; 2024 Mar; 7(3):e242727. PubMed ID: 38497960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of environmental factors with neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia (ALL).
    Nigro SE; Hall LP; Harman J; Willard VW; Conklin HM; Pui CH; Jeha S; Jacola LM
    Support Care Cancer; 2023 Dec; 32(1):1. PubMed ID: 38047975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.